NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Shire Pharmaceuticals 

725 Chesterbrook Boulevard

Wayne  Pennsylvania  19087-5637  U.S.A.
Phone: 484-595-8800 Fax: 484-595-8900


SEARCH JOBS


Founded in 1986, Shire is a fast-growing global specialty biopharmaceutical company with 2008 revenues of $3 billion and over 3,500 employees worldwide. A global leader working to meet the needs of the specialist physician and the patients they serve, Shire today has a presence in 23 countries and medicines available in nearly 40 countries. We focus on the therapeutic areas of attention deficit hyperactivity disorder (ADHD), gastrointestinal (GI), and genetic disorders. Encouraging our employees to be innovative, to take measured risks, and to act on the needs of our patients help define Shire and our people.

Our operation is structured in two complementary businesses – Human Genetic Therapies (HGT), and Specialty Pharmaceuticals – that are each supported by various corporate functions. With a major presence in Massachusetts, our HGT team specializes in researching, developing, and commercializing therapies for the treatment of rare genetic diseases caused by protein deficiencies. Shire’s Specialty Pharmaceuticals team, with major operations in Pennsylvania, is made up currently of three business units – ADHD, GI, and Emerging Products. This team also oversees many other marketed medicines approved to help people around the world.

By encouraging trust and openness in all we do, Shire has evolved through strategic acquisitions into a unique, nimble organization that is able to act quickly and take advantage of business opportunities as they arise. Through a culture that allows all employees to potentially impact and shape our business, Shire distinguishes itself from other biopharma organizations. Working as a team, our employees strive to continually achieve our purpose of enabling people with life-altering conditions to lead better lives.

We are always looking for talented people to join the Shire team. To learn more about Shire, visit www.shire.com. For more information on career opportunities with Shire, please visit: www.TimeToBeBrave.com.

Shire ... To be as brave as the people we help.


 Key Statistics


Email:
Ownership:
Web Site: Shire Pharmaceuticals
Employees: 336
Symbol: SHPGY
 



Industry
Pharmaceutical






 Company News
Shire Pharmaceuticals (SHPGY) Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants 11/16/2009 8:52:32 AM    More...
US FDA Warns Shire Pharmaceuticals (SHPGY) (JOBS), Eisai Company, Ltd. (ESALY.PK) (JOBS) on Promotions 11/16/2009 7:05:57 AM    More...
Shire Pharmaceuticals (SHPGY) (JOBS) to Pour $460M, 750 Jobs into Lexington, Massachusetts 8/20/2009 8:48:23 AM    More...
Shire Pharmaceuticals (SHPGY), Johnson & Johnson (JNJ) Win Key Drug Data Case at Top EU Court 6/18/2009 7:33:49 AM    More...
Shire Pharmaceuticals (SHPGY) Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion 2/19/2009 10:33:51 AM    More...
Shire Pharmaceuticals (SHPGY) Investor Seminar 11/18/2008 10:21:52 AM    More...
Wolf Greenfield Wins Three More Years of Patent Protection for Shire Pharmaceuticals (SHPGY)' ELAPRASE 8/17/2008 10:59:46 PM    More...
BioPharm America™ Features Top Industry Decision-Makers in Life Science Partnering 6/25/2008 9:55:21 AM    More...
EBD Group Release: BioPharm America(TM) Features Top Industry Decision-Makers in Life Science Partnering 6/25/2008 8:10:53 AM    More...
Shire Pharmaceuticals (SHPGY) Announces Approval of ELAPRASE(R) (idursulfase) in Brazil First and Only Treatment for Hunter Syndrome Now Approved in 40 Countries Worldwide 5/27/2008 7:15:35 AM    More...
12345678910...